Monthly Prescribing Reference2h
AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
In the univariate analysis, those on an SGLT-2i/GLP-1 RA had a reduced risk for mortality, incident MI, and composite. (HealthDay News) — For patients with ischemic stroke, sodium-glucose ...
Monthly Prescribing Reference2h
FDA Denies Full Approval of Obeticholic Acid for Primary Biliary Cholangitis
The sNDA was submitted to support full approval of OCA for this indication based on data from the COBALT trial, as well as real-world evidence.
Monthly Prescribing Reference2h
Virtual Yoga Classes Aid Chronic Low Back Pain
(HealthDay News) — Virtual yoga classes may be a feasible, safe, and effective treatment option for chronic low back pain (CLBP), according to a study published online Nov. 1 in JAMA Network Open.
Monthly Prescribing Reference2h
US Physicians Rarely Disciplined for Spreading Medical Misinformation
Spreading medical misinformation to the public and providing misinformation to patients receiving treatment were among the least common reasons for discipline. A large study suggests that, across the ...
Monthly Prescribing Reference20h
Magstim Horizon Inspire TMS System Cleared for Depression, OCD Treatment
The Horizon® 3.0 Inspire has a compact design allowing for easier portability. The Food and Drug Administration (FDA) has cleared Magstim’s Horizon ® 3.0 Inspire for the treatment of major depressive ...
Monthly Prescribing Reference20h
SGLT-2 Inhibitors Beneficial for Patients With Nephrolithiasis
Researchers emulated target trials comparing recurrence of nephrolithiasis among patients with preexisting nephrolithiasis initiating SGLT-2 inhibitors vs an active comparator. (HealthDay News) — For ...